Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
=====================================================================================================================================================

* Brian I Rini
* Sabina Signoretti
* Toni K Choueiri
* David F McDermott
* Robert J Motzer
* Saby George
* Thomas Powles
* Frede Donskov
* Scott S Tykodi
* Sumanta K Pal
* Saurabh Gupta
* Chung-Wei Lee
* Ruiyun Jiang
* Nizar M Tannir